about
Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal CancerMaximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.Optimising delineation accuracy of tumours in PET for radiotherapy planning using blind deconvolution.Application of metabolic PET imaging in radiation oncology.Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT : part 1.Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancerUse of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity.Cancer biomarker discovery: current status and future perspectives.Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis.Biological imaging in clinical oncology: radiation therapy based on functional imaging.Salvage radiotherapy in patients with recurrent esophageal carcinoma.Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute.Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin's lymphoma. A case study.Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer.Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning.Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity.Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcome.Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience.Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.
P2860
Q26753864-367044A2-E476-484C-8B05-F6002F59BC3EQ33750851-75C0A4BF-37FC-4339-A252-1C81F09FD0B1Q35849051-C2FB06CB-9D2D-4EC6-B10A-F0079D24696EQ37580845-197AE33D-7859-4632-9445-8D2420B0B605Q37938691-7EC31B3F-9CE9-4D74-9258-1447EDDDCE21Q37970570-F23D3911-18BC-4FEB-80C0-465C7EDF6B02Q37975010-1C83E1F1-3187-4263-9990-996645404709Q38016163-836C22BB-021C-4CFA-ADA0-BFD8378E4753Q38036587-A9DF1AE5-1245-4CDA-89F2-A0D9318406E5Q38187679-A61A09E4-8E76-4A27-B768-34D4D624C44BQ38645296-D0138DE0-BE9A-4C95-9F6A-F807BD3B0BACQ38887987-A3418F3D-DACC-4190-9880-05FAAA112C0BQ39253778-B211FA8E-BEDE-491A-A998-CEB4DF422B15Q39520534-99B2CCEA-E7E3-4053-ADBB-13639C0EA354Q39539001-CADBD039-5578-4400-8DD4-EE41B38AD908Q41677756-581E8D03-F1E6-43EA-BDB9-1027449A2F82Q42041284-140AF342-EBA6-4B34-A274-8810EF041CF9Q43919851-0AFA1732-B82C-45D8-97E3-0D0BE1FBF68CQ44020055-D3F4B2C8-7879-4FF5-B259-1FDD76BF09F8Q47990889-3AB8B61C-209D-4EB1-9789-6895A1885B63Q49026485-52C648B1-649A-4F84-9296-703A30680E22Q49115489-747B942E-9897-48C0-B1F6-015C0DE9D1B8Q53084551-E626CEC4-CEAC-4F50-BB40-FF629487EE83
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of FDG-PET to target tumors by radiotherapy.
@en
The use of FDG-PET to target tumors by radiotherapy.
@nl
type
label
The use of FDG-PET to target tumors by radiotherapy.
@en
The use of FDG-PET to target tumors by radiotherapy.
@nl
prefLabel
The use of FDG-PET to target tumors by radiotherapy.
@en
The use of FDG-PET to target tumors by radiotherapy.
@nl
P2093
P2860
P1476
The use of FDG-PET to target tumors by radiotherapy.
@en
P2093
Brigitta G Baumert
Guido Lammering
Jacques Borger
Ludy Lutgens
Michel Ollers
Philippe Lambin
Piet van den Ende
P2860
P2888
P304
P356
10.1007/S00066-010-2150-1
P577
2010-08-30T00:00:00Z